Herpesvirus-based infectious titering of recombinant adeno-associated viral vectors

Molecular Therapy

Volumn 11, Issue 2, 2005, Pages 320-326

  Mohiuddin, Imran ^a   Loiler, Scott ^a   Zolotukhin, Irina ^a   Byrne, Barry J ^a   Flotte, Terence R ^a   Snyder, Richard O ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Adeno associated virus; Gene therapy; Herpesvirus; Serotype; Titer

Indexed keywords

CAPSID PROTEIN; HELICASE; HERPESVIRUS VECTOR; LUCIFERASE; PARVOVIRUS VECTOR; REAGENT; YELLOW FLUORESCENT PROTEIN;

ARTICLE; CALCULATION; CELL LINE; GENE EXPRESSION; GENE FUNCTION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; NONHUMAN; RELIABILITY; RISK REDUCTION; SAFETY; SEROTYPE; VIRAL GENE DELIVERY SYSTEM; VIRUS CAPSID; VIRUS GENOME; VIRUS RECOMBINANT;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DEPENDOVIRUS; GENETIC VECTORS; GENOME, VIRAL; HELPER VIRUSES; HUMANS; RATS; SEROTYPING; SIMPLEXVIRUS;

ADENO-ASSOCIATED VIRUS; ANIMALIA; HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 12744263418     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.08.030     Document Type: Article

References (50)

1. E.A. Rutledge C.L. Halbert and D.W. Russell Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2 J. Virol. 72 1998 309-319
2. W. Xiao N. Chirmule S.C. Berta B. McCullough G. Gao and J.M. Wilson Gene therapy vectors based on adeno-associated virus type 1 J. Virol. 73 1999 3994-4003
3. B.L. Davidson et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system Proc. Natl. Acad. Sci. USA 97 2000 3428-3432
4. G.P. Gao M.R. Alvira L. Wang R. Calcedo J. Johnston and J.M. Wilson Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy Proc. Natl. Acad. Sci. USA 99 2002 11854-11859
5. H. Chao Y. Liu J. Rabinowitz C. Li R.J. Samulski and C.E. Walsh Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors Mol. Ther. 2 2000 619-623
6. D. Grimm M.A. Kay and J.A. Kleinschmidt Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6 Mol. Ther. 7 2003 839-850
7. P.L. Hermonat and N. Muzyczka Use of adeno-associated virus as a mammalian DNA cloning vector: Transduction of neomycin resistance into mammalian tissue culture cells Proc. Natl. Acad. Sci. USA 81 1984 6466-6470
8. J.A. Chiorini L. Yang Y. Liu B. Safer and R.M. Kotin Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles J. Virol. 71 1997 6823-6833
9. J.A. Chiorini F. Kim L. Yang and R.M. Kotin Cloning and characterization of adeno-associated virus type 5 J. Virol. 73 1999 1309-1319
10. J.E. Rabinowitz et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity J. Virol. 76 2002 791-801
11. H. Buning et al. Receptor targeting of adeno-associated virus vectors Gene Ther. 10 2003 1142-1151
12. L. Perabo et al. In vitro selection of viral vectors with modified tropism: The adeno-associated virus display Mol. Ther. 8 2003 151-157
13. S.A. Loiler et al. Targeting recombinant adeno-associated virus vectors to enhance gene transfer to pancreatic islets and liver Gene Ther. 10 2003 1551-1558
14. R.M. Kotin et al. Site-specific integration by adeno-associated virus Proc. Natl. Acad. Sci. USA 87 1990 2211-2215
15. R.J. Samulski et al. Targeted integration of adeno-associated virus (AAV) into human chromosome 19 EMBO J. 10 1991 3941-3950
16. M.D. Weitzman S.R. Kyostio R.M. Kotin and R.A. Owens Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA Proc. Natl. Acad. Sci. USA 91 1994 5808-5812
17. W.G. Kearns et al. Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line Gene Ther. 3 1996 748-755
18. H. Nakai et al. Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice Mol. Ther. 7 2003 101-111
19. R.O. Snyder X. Xiao and R.J. Samulski Production of recombinant adeno-associated viral vectors In: (N. Dracopoli J. Haines B. Krof D. Moir C. Morton C. Seidman J. Seidman and D. Smith, Eds.) Current Protocols in Human Genetics 1996 Wiley New York 12.1.1-12.1.24
20. M. Potter K. Chesnut N. Muzyczka T. Flotte and S. Zolotukhin Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors Methods Enzymol. 346 2002 413-430
21. K.R. Clark F. Voulgaropoulou D.M. Fraley and P.R. Johnson Cell lines for the production of recombinant adeno-associated virus Hum. Gene Ther. 6 1995 1329-1341
22. J.E. Conway et al. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap Gene Ther. 6 1999 986-993
23. G.P. Gao et al. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus Hum. Gene Ther. 9 1998 2353-2362
24. S. Zolotukhin et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield Gene Ther. 6 1999 973-985
25. S. Zolotukhin et al. Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors Methods 28 2002 158-167
26. N. Kaludov B. Handelman and J.A. Chiorini Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography Hum. Gene Ther. 13 2002 1235-1243
27. A. Auricchio E. O'Connor M. Hildinger and J.M. Wilson A single-step affinity column for purification of serotype-5 based adeno-associated viral vectors Mol. Ther. 4 2001 372-374
28. N. Brument et al. A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5 Mol. Ther. 6 2002 678-686
29. N. Kaludov K.E. Brown R.W. Walters J. Zabner and J.A. Chiorini Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity J. Virol. 75 2001 6884-6893
30. G.D. Di Pasquale et al. Identification of PDGFR as a receptor for AAV-5 transduction Nat. Med. 9 2003 1306-1312
31. C. Summerford and R.J. Samulski Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J. Virol. 72 1998 1438-1445
32. C. Summerford J.S. Bartlett and R.J. Samulski AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection Nat. Med. 5 1999 78-82
33. K. Qing C. Mah J. Hansen S. Zhou V. Dwarki and A. Srivastava Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2 Nat. Med. 5 1999 71-77
34. J. Qiu and K.E. Brown A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid Virology 257 1999 373-382
35. K. Qing J. Hansen K.A. Weigel-Kelley M. Tan S. Zhou and A. Srivastava Adeno-associated virus type 2-mediated gene transfer: Role of cellular fkbp52 protein in transgene expression J. Virol. 75 2001 8968-8976
36. K.R. Clark F. Voulgaropoulou and P.R. Johnson A stable cell line carrying adenovirus-inducible rep and cap genes allows for infectivity titration of adeno-associated virus vectors Gene Ther. 3 1996 1124-1132
37. E.M. Atkinson D.J. Debelak L.A. Hart and T.C. Reynolds A high-throughput hybridization method for titer determination of viruses and gene therapy vectors Nucleic Acids Res. 26 1998 2821-2823
38. K.R. Clark X. Liu J.P. McGrath and P.R. Johnson Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses Hum. Gene Ther. 10 1999 1031-1039
39. L. Drittanti C. Rivet P. Manceau O. Danos and M. Vega High throughput production, screening and analysis of adeno-associated viral vectors Gene Ther. 7 2000 924-929
40. Z. Zhen Y. Espinoza T. Bleu J.M. Sommer and J.F. Wright Infectious titer assay for adeno-associated virus vectors with sensitivity sufficient to detect single infectious events Hum. Gene Ther. 15 2004 709-715
41. B. Yakobson T.A. Hrynko M.J. Peak and E. Winocour Replication of adeno-associated virus in cells irradiated with UV light at 254 nm J. Virol. 63 1989 1023-1030
42. X.J. Jing V. Kalman-Maltese X. Cao Q. Yang and J.P. Trempe Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus Virology 291 2001 140-151
43. A. Salvetti et al. Factors influencing recombinant adeno-associated virus production Hum. Gene Ther. 9 1998 695-706
44. L.C. Mathews J.T. Gray M.R. Gallagher and R.O. Snyder Recombinant adeno-associated viral vector production using stable packaging and producer cell lines Methods Enzymol. 346 2002 393-413
45. J.E. Conway S. Zolotukhin N. Muzyczka G.S. Hayward and B.J. Byrne Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap J. Virol. 71 1997 8780-8789
46. J.A. Chiorini S. Afione and R.M. Kotin Adeno-associated virus (AAV) type 5 Rep protein cleaves a unique terminal resolution site compared with other AAV serotypes J. Virol. 73 1999 4293-4298
47. B. Hirt Selective extraction of polyoma DNA from infected mouse cell cultures J. Mol. Biol. 26 1967 365-369
48. G.A. Visner S.E. Chesrown J. Monnier U.S. Ryan and H.S. Nick Regulation of manganese superoxide dismutase: IL-1 and TNF induction in pulmonary artery and microvascular endothelial cells Biochem. Biophys. Res. Commun. 188 1992 453-462
49. F.L. Graham J. Smiley W.C. Russell and R. Nairn Characteristics of a human cell line transformed by DNA from human adenovirus type 5 J. Gen. Virol. 36 1977 59-74
50. D.T. Ross et al. Systematic variation in gene expression patterns in human cancer cell lines Nat. Genet. 24 2000 227-235